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1. Introduction
In organic chemistry one of the main challenges, and the cause of intense research from
groups all around the globe, lie within asymmetric synthesis. Asymmetric synthesis/
induction is an old concept that can be traced back to the study by Emil Fischer in 1894
on the origin of the carbohydrate stereochemistry and the development of the Kiliani-
Fischer synthesis (Scheme 1). 1,2,3 Although the apparent age of these groundbreaking
ideas, this type of chemistry still leaves room for big improvements. During the years
since, impressive achievements in the total synthesis of highly complex natural products
have been the frontier in the development of new protocols for asymmetric
transformations. Despite this fact, it still remains difficult to obtain complete
enantiospecific control over reactions.
2
D
D
Scheme 1. Classic Kiliani-Fischer synthesis, homologation of D-arabinose to D-glucose
and D-mannose
One strategy to synthesize chiral compounds is to pass on the stereochemical information
to the end product by the use of chiral starting materials, from the so called “chiral pool”.
Nature, of course, the biggest supplier of chiral starting materials, provides us with a
range of useful compounds, e.g. amino acids, sugars and terpenes, as single enantiomers
in large quantities at an affordable price. The use of compounds from the chiral pool in
synthetic organic chemistry is by no means a new strategy. Due to the obvious simplicity
and the relative inexpensiveness of the starting material that the method offers in creating
stereogenic centers it has been widely used in the synthesis of natural products and other
compounds of medicinal and/or industrial importance.4
There are 23 proteinogenic amino acids (20 of which are encoded straight from the
genome by triplet codons), however including the non-proteinogenic ones, the total
number of naturally occurring amino acids is far higher. Many of these compounds
contain at least one chiral center and are also commercially available in significant
15
quantities at a low price. More than that, the amino acids are, obvious by their
nomenclature, equipped with at least two functional groups, which can be subjected to a
huge number of synthetic manipulations, making them extremely versatile building
blocks for a large range of chemical applications. However, the use of chiral amino acids
in synthetic organic chemistry does suffer from some critical limitations, hampering their
usability. The valuable synthetic intermediates of e.g. chiral α-amino-aldehydes, -ketones,
-esters and amides derived from amino acids serve as illustrative examples (Figure 1).
The acidity of the α-proton makes these compounds vulnerable towards
racemization/epimerization and ultimately not suitable for carriers of stereogenic
information under certain reaction conditions. Methods to overcome these specific
limitations are therefore in great demand.
Figure 1. Racemization of α-amino carbonyl compounds via an enolization mechanism
In order to deal with the abovementioned racemization/epimerization issues, the 9-
phenyl-fluoren-9-yl (Pf) group was introduced by Henry Rapoport, in 1985.5,6 Rapoport
originally utilized the strategy in the synthesis of (+)-apovincamine from asparagine, to
regioselectively direct enolate formation away from the vulnerable stereocenter
(described more detail in chapter 2.2.1). Rapoport also quickly realized the potential of
such a protecting group, expanding the scope to show that N-Pf α-amino aldehydes were
configurationally stable,7 and also started to routinely incorporate the strategy in various
synthetic endeavours.8 Many former students of Rapoport’s subsequently picked up on
the concept, after leaving his research team to pursue their own careers, and the Pf-
protecting group consequently made its journey from sunny Berkeley California to cold
Espoo Finland, finally ending up in my humble hands.
This dissertation describes the use of the Pf-protecting group in the synthesis of
tetrahydro-β-carbolines (THβCs), a prominent family of indole alkaloids, starting from
amino acids.9 Examples from this family include tryptoline which makes up the basic
16
structural skeleton of the THβCs, the natural products sarpagine, vincamine and
ajmalicine, the antihypertensive agent reserpine,10 the antiviral compound eudistomin C11
and the synthetic THβC tadalafil, 12   a powerful PDE5 inhibitor and block buster
pharmaceutical (Figure 2A). The following discussion will focus on the transfer of the
chiral center present in the starting amino acids, to the C-1 position of the THβC C-ring
(Figure 2B). The Pf-group is employed within this work to ensure complete
configurational stability of the amino acid derivatives. The first chapters consist of a
condensed literature overview of Pf-protecting group chemistry, including some selected
applications, as well as a look into the world of THβCs. The discussion will then proceed
to include a summary of the chemistry developed within the framework of this thesis,
starting with the synthesis of harmicine,I,II eleagnineIII and chiral 2-indolyl aminesIV and
ending on a discussion regarding the mechanism of the Pf-protecting groups ability to
maintain the configurational stability of chiral α-amino carbonyl compoundsIV.
Figure 2. A) Representative examples of THβCs. B) Fundamental principle discussed
within the framework of this dissertation. R = amino acid side chain.
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2. The 9-phenyl-fluoren-9-yl protecting group in organic
synthesis
2.1. Properties of the Pf-protecting group
The story begins in 1981 with Guthrie’s seminal study on the trityl (Tr) group and its
ability to maintain the stereochemical integrity of phenylalanine dimethylamide
derivative under harsh basic conditions. 13  Guthrie observed that when treating N-
pivalylphenylalanine dimethylamide 1 with t-BuOK in t-BuOD, the rate of
proton/deuterium exchange was greater than the rate of racemization (Scheme 2). An
early example of the phenomenon that today would be described as memory of chirality
(MOC), a concept coined 14  in 1991 and coeval with one of the earliest published
examples by Seebach.15 Speculating on the role of the steric bulk of the N-substituent,
they synthesized compound 3 and subsequently submitted the substrate to the same
racemizing reaction conditions. They found that, even at elevated temperature, the
proton/deuterium exchange was slowed down to an almost complete stop. After keeping
the reaction going for weeks at 120 oC, only 50% deuterium incorporation could be
observed. Also, despite the extra bulk introduced to the phenylalanine substrate, no
stereospecifity in the proton/deuterium exchange was detected.
Scheme 2. Stereospecifity of proton/deuterium exchange in 1 and 2; ke = rate constant of
proton/deuterium exchange; ka = rate constant of loss of optical activity.
Later the concept was picked up by Rapoport during his synthetic studies on (+)-
apovincamine. (Chapter 2.2.1). Rapoport however found that the corresponding N-Tr-
compounds were too labile towards acidic solvolysis, e.g. during silica gel
chromatography, to be of practical use. Instead he introduced the idea of using the
analogous Pf-group as an amine protecting group. Pf-Cl was known to be 6000 times less
reactive than Tr-Cl in solvolysis studies.16 The increased acid stability can be accredited
to the lower stability of the Pf-carbenium ion due to its antiaromatic character.17 Rapoport
also went on to synthesize N-Pf-L-alaninal 5, and proving it to be configurationally stable
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towards basic conditions as well as towards silica gel chromatography.7 Rapoport noted
that when refluxing aldehyde 5 in THF for 8 h together with 100 mol-% Et3N, 50% of the
starting material decomposed (Scheme 3).  Investigation of the reaction mixture showed
the other major reaction component to be 9-phenylfluorene, indicating a base induced
elimination reaction of a 9-phenylfluoren-9-yl anion. Investigation of the remaining 50%
of starting material showed no degradation in the enantiopurity. Based on these
observations Rapoport came to the conclusion that the base induced elimination reaction
must be faster than the corresponding deprotonation/reprotonation reaction that would
cause racemization. The corresponding elimination reaction of e.g. compound 3 could
however be considered unlikely due to the large difference in the pKa values of Tr-H (pKa
31.5)18 and Pf-H (pKa 18.5)19 which is due to the aromatic nature of the 9-phenylfluoren-
9-yl anion.
Scheme 3. Base induced elimination of 9-phenylfluoren-9-yl anion from aldehyde 5
The introduction of the Pf-group onto an amino acid derivative is fairly straightforward
and high yields can routinely be achieved.20 Pf-Br, which is commercially available albeit
at a rather hefty price, is used as the Pf-source. Alternatively, Pf-Br can easily be
synthesized in large scales, using a two-step procedure from fluorenone. 21  Typical
conditions for the 9-phenylfluoren-9-ylations involve treating the amino acid with Pf-Br
in the presence of a base and Pb(NO3)2 as a bromide scavenger (Scheme 4). If there are
free hydroxyl groups, including carboxylic acids, present on the substrate, an in situ
protection as the TMS ether, or ester, might be called for, as is exemplified by the Pf-
protection of alanine 7 (Scheme 4). The removal of the Pf-group can easily be
accomplished under both hydrogenolysis22 and acidic solvolysis23.
There have been some speculations to how the Pf-group is able to so effectively shield the
α-carbon on α-amino acid derivatives from racemization. Except for the obvious steric
19
shielding that the Pf-group imposes, it has also been put forth that stereoelectronic effects
might play a role for the unprecedented configurational stability exhibited by these
substrate. Molecular mechanics (MM) calculations have shown the Hα to be
antiperiplanar or alternatively periplanar to the carbonyl C=O bond. 24  Such a
conformation would effectively minimize the interaction between the C-Hα σ-orbital and
the C=O π*-orbital, leading to a lowering of the Hα acidity. This theory has indeed found
some support in crystallographic measurements. 25 , 26  However, until now no
comprehensive investigations had been undertaken which will be discussed further in
chapter 4.IV
Scheme 4. 9-phenylfluoren-9-ylation of alanine and dimethyl aspartate
2.2. Notable examples in synthesis
There exist quite a number of total synthesis of natural products employing a Pf-
protecting group strategy and below will follow some successful applications of the Pf-
protecting group in natural product synthesis. Three such cases will be presented in more
detail. Additional examples include, e.g. the total synthesis of polytheonamide B,27 (-)-
kainic acid,28 different anisomycin derivatives,29 (+)-vincamine,30 ribasine,31 microcystin
LA32 and homo-sphingosine.26
2.2.1. Total synthesis of (+)-apovincamine
The pioneering study on the use of the Pf-group as an N-protecting group in total
synthesis was performed by Henry Rapoport in 1985 during his synthetic studies on the
THβC apovincamine, a monoterpenoid alkaloid belonging to the Aspidosperma class of
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indole alkaloids (Scheme 5A).5,33 The synthesis started with the synthesis of iodide 11,
which  was  straightforwardly  prepared from L-asparagine  in  7  steps. Next, in  the  key
Scheme 5. A) The Pf-protecting group in the synthesis of (+)-apovincamine from L-
aspargine. B) Regioselectivity in the treatment of 15 with LDA and EtI
reaction step they aimed to ring close iodide 11 to the corresponding pipecolate, via
chemoselective enolization of the C-2 position without risking racemization
/epimerization at C-1. Based on the knowledge regarding the ability of the Tr-group to
suppress proton/deuterium exchange in phenyl alanine derivative 3 to almost a complete
stop (vide supra) they opted to try the reaction using the more stable and similar sized Pf-
group. To their delight, when treating compound 11 with an excess of LDA in the
presence of EtI they obtained a mixture of 12 and 13, with full retention of the C-1
stereochemistry and complete stereocontrol at C-2 in the introduction of the ethyl group.
The stereocontrol at C-2 could be attributed to the rigid piperidine ring structure, wherein
the benzyl ester group is occupying an axial position, due to the bulkiness of the
equatorial Pf-group, leading to the highly selective alkylation. It is interesting to note that
the benzyl ester present in the substrate was also alkylated to a significant degree. They
also found the same mode of reactivity when treating pipecolate 15 with LDA and
quenching the reaction with EtI, to give compound 16 in a moderate 65% yield (Scheme
5B). This reaction really showcases the Pf-protecting group’s potential to block the C-1
position from enolization, but also serves to illustrate that rather unique regioselectivities
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can be achieved by employing this type of chemistry. The total synthesis was then
completed by forming the THβC ring scaffold via a phenylphosphonic dichloride
mediated decarbonylation, substitution of the indole N-H with methyl bromoacetate
followed by a Dieckmann condensation and finally ketone reduction/dehydration
affording (+)-apovincamine.
2.2.2. Total synthesis of (+)-pilocarpine
Next we have yet another total synthesis by Rapoport, i.e. the total synthesis of (+)-
pilocarpine (Scheme 6).34 The synthesis started from L-aspartic acid, which was esterified
and N-Pf protected to diester 17. One of the key steps, the diastereoselective alkylation of
17 with ethyl triflate was then performed. Very high selectivity was achieved (18:1), and
batches of up to 60 g of starting material could be run without any problems, show casing
once again the Pf-groups capability of regioselectively directing the enolization. Next, the
amino acid nitrogen was substituted with a bromide, to give bromo ester 19, via a four
step reaction sequence consisting of hydrogenolysis, selective ester hydrolysis,
diazotization in the presence of HBr/KBr and finally Fischer esterification. A
Reformatsky reaction between bromo ester 19 and aldehyde 20, mediated by Zn(Ag)
together with Me2AlCl, gave lactone 21 as the major isomer, in good selectivity. Lastly,
lactone 21 was transformed into (+)-pilocarpine after hydrogenolysis and ester
reduction/lactonization.
Scheme 6. Total synthesis of (+)-pilocarpine from L-aspartic acid
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2.2.3. Total synthesis of despilairind, preparation of a dihydroxy methyl
proline fragment
Lastly we have the total synthesis of despilairdin (Scheme 7), a more recent example by
Ward and co-workers, in which a dihydroxy methyl proline fragment 23 was prepared by
Pf-protecting group chemistry.35 First, trans-4-hydroxy-L-proline was subjected to Fischer
esterification, 9-phenyl-fluoren-9-ylation and Swern oxidation to give ketone 24
according to Sardina’s studies on polyhydroxylated pyrrolidones. 36  The sodium enolate
of ketone 24, regioselectively controlled by the aid of the Pf-group, was then treated with
Vedejs’ reagent to give hydroxyl ketone 25 as a single diastereomer. MOM-protection of
the hydroxyl group followed by methylation gave ketone 26, as the major diastereomer,
due to the pseudo equatorial alignment of the methyl ester group in the potassium
enolate.37 NaBH4 reduction of ketone 26 furnished the dihydroxy methyl proline fragment
27, corresponding to building block 23, to be used in the total synthesis of depsilairdin.
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Scheme 7. Total synthesis of depsilairdin, synthesis of fragment 27 (corresponding to
fragment 23); Pg = protecting group
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2.3. Alternative ways of combating racemization in amino acid
derived compounds
The racemization sensitivity of α-amino carbonyl compounds is, and has been, a well-
known problem.38 As a consequence several methods addressing this dilemma, apart from
the use of Tr- or Pf-protecting group chemistry, exist in the chemical literature. Some of
these methods will be described below.
2.3.1. Garner’s aldehyde
It would almost be considered as sacrilegious to not address the case of Garner’s
aldehyde when discussing the topic of natural product synthesis utilizing amino acids.39
Garner’s aldehyde 28 was introduced by Philip Garner in 1984. It is a fully protected
serine derivative, configurationally stable (to purification on silica gel, vacuum
distillation and during prolonged storage) building block that has found tremendous use
in organic synthesis,40 especially in the synthesis of sphingolipids, as illustrated by one of
Garner’s pioneering studies on sphingosine (Scheme 8). In his study, Garner’s aldehyde
was treated with lithiated 1-pentadecyne. Predominant Re-face attack furnished amino
alcohol 29, which after partial reduction of the triple bond and protecting group removal
gave D-erythro-sphingosine 30 in a very straight forward manner. Garner also found that
he could achieve reversal of the diastereoselectivity by treating Garner’s aldehyde 28 by
using the trans-vinylalane, derived from hydroalumination of 1-pentadecyne using
DIBAL. 41  After protecting group removal D-threo-sphingosine 32 was accordingly
obtained.
Scheme 8. Garner’s sphingosine synthesis
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2.3.2. N,N-dibenzylamino aldehydes
The use of N,N-dibenzylamino aldehydes 33 were popularized by Manfred Reetz in the
late 1980’s. 42  Their introduction was advertised as a general fix to ensure
configurationally stability in combination with high stereoselectivity in both chelation
controlled and non-chelation controlled addition reactions - depending on the choice of
nucleophile (Scheme 9).43 However, the claimed configurational stability was not to be
considered general. Storage of the derivatives for prolonged periods of time, as well as
subjecting the compounds to acids or bases could lead to degradation of the enantiopurity.
In fact, silica gel chromatography was shown to completely racemize a phenyl alanine
derived N,N-dibenzylamino aldehyde. 44  Hence, a certain measure of care must be
undertaken in order to successfully use these types of derivatives, and in general the
compounds are best used freshly prepared as crude materials.
Scheme 9. Chelation versus non-chelation control in organometallic addition reactions to
a generalized N,N-dibenzylamino aldehyde 33
2.3.3. N-carbamate protected α-amino aldehydes
Carbamate protected α-amino aldehydes, although attractive synthetic intermediates are
notoriously prone to racemization (Table 1).45,46 Despite this generally accepted fact,
these compounds can and have found uses. The trick is obviously once again to avoid
excessive purification and prolonged storage at elevated or even ambient temperatures.
The total synthesis of (+)-actinobolin serves as an illustrative example (Scheme 10).47
Methyl ester 40 was first synthesized from L-threonine in 3 steps. DIBAL-H reduction of
ester 40, followed by an aqueous work up furnished aldehyde 41, which was then
immediately reacted further to enone 42 via a Wittig reaction. It was found to be
necessary, owing to the aforementioned issues, to telescope the DIBAL reduction/Wittig
reaction thereby avoiding epimerization issues of 41 upon silica gel purification. A 12
step sequence then transformed enone 42 into actinobolin.
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Table 1. Configurational stability of carbamate protected α-amino aldehydes towards
silica gel and prolonged storage45,46
During subjection to SiO2 During Storage
Compound Degree of
Racemization
Compound Time Temp Ratio
6 h 22 h [Days] [oC] L/D
53% 85% 1 -30 99/1
32% 65% 9 -30 99/1
99% 100% 9 +24 7/3
Scheme 10. Total synthesis of (+)-actinobolin
2.3.4. Reagent control
The last example presented involves the rather obvious way of applying a case to case
trial and error approach. In the world of peptide synthesis, i.e. amide bond formation,
such examples are plentiful. In fact, a large amount of coupling reagents and additives has
been developed for the purpose of suppressing racemization along the course of the
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reactions.38b Also, a range of screening methods, in order to evaluate and compare
different reaction conditions used in amide couplings reactions, was developed early on.48
The effect of a judicious choice of reagents and its influence on enantiopurity, was very
well illustrated in the synthesis of 3-piperidinols from our laboratory when Weinreb
amide 45 was targeted as a key building block (Scheme 11). 49,50 Fully protecting L-
phenylglycine 43 as the corresponding N,N-benzylbenzyloxycarbonyl compound 44 was
easily accomplished by a telescoped reaction sequence. Next the Weinreb amide
formation was investigated. The best result was obtained by employing
dicyclohexylcarbodiimide (DCC) in combination with N-methylmorpholine (NMM)
(pKaH 7.38) giving an ee of 95%, a quite impressive feat when taking into account the
extreme configurational lability of phenylglycine derivatives.51 Use of a stronger base,
Et3N (pKaH 10.75) with standard additives such as dimethylaminopyridine (DMAP) or
hydroxybenzotriazole (HOBt) caused significant amounts of racemization. Also, adding
DMAP together with the DCC/NMM procedure proved detrimental. Using a more
recently developed methodology, employing the coupling reagent propylphosphonic
anhydride (T3P®) in combination with pyridine also racemized the substrate
significantly.52 The synthesis proceeded from amide 45 to provide the neurokinin 1 (NK-
1) inhibitor L-733,060 in 6 steps.53
Scheme 11. Synthesis of L-733,060-HCl via Weinreb amide 45
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3. Tetrahydro-β-carbolines
THβCs, the C-ring saturated analogues of β-carbolines (βCs) (for atom numbering and
ring assignment, see Figure 2), which in itself is a subgroup of the indole alkaloids,
comprise a vast amount of compounds. Of special importance are the chiral C-1
substituted THβCs alkaloids, a prominent collection of natural products containing e.g.
the corynantheine, yohimbine and eburnamine-vincamine types of monoterpenoid
alkaloids. 54,55,56 Also a large amount of more structurally simple alkaloids, denoted as
“simple THβCs”, can also be found within the THβC family, examples include harmicine,
trypargine, borrerine and eleagnine (Figure 3).57 The following chapter will highlight
some of the different methodologies that have successfully been applied in the
asymmetric synthesis of THβCs, leading up to the presentation of the authors own
research results. The literature review presented below does not aim to cover the entire
research field, but instead aims to offer insight into the most important methodologies,
emphasized with selected examples.
Figure 3. Monoterpeniod alkaloid subtypes (corynantheine, yohimbine and eburnamine)
as well as examples of some of the simple THβC (harmicine, trypargine, eleagnine and
borrerine)
3.1. Synthetic methodologies towards THβCs
3.1.1. Biosynthesis
The biosynthesis of THβCs relies on the condensation reaction between a tryptamine and
an aldehyde, to form the tricyclic ring structure. This reaction was first discovered in
1911, during explorations on the synthesis of tetrahydroisoquinolines (THIQs). The
reaction was subsequently named the Pictet-Spengler reaction (PSR) after its inventors.58
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Much later, in 1977, the first Pictet-Spenglerase, strictosidine synthase (STR), was
discovered in nature, a discovery that culminated in the elucidation of the biosynthetic
pathway of the monoterpeniod alkaloid ajmalicine. 59 , 60 , 61 It was shown that STR
efficiently catalyzed the reaction between tryptamine and secologanin 46 to give
strictosidine (Scheme 12). Strictosidine is then the starting point in the biosynthesis for a
large array of THβC (including e.g.  reserpine). It is also the starting point for a number
of other alkaloids, such as the famous Strychnos alkaloid strychnine; and the quinoline
alkaloid quinine. The existence of Pictet-Spenglerases has obviously exploited in
asymmetric synthesis and the scope of the enzymatic reaction has been extended to allow
different tryptamines and aldehydes to be used as substrates.60,62
Scheme 12. STR catalyzed PSR of tryptamine and secolaganin 46; Glc = glucose
3.1.2. Pictet-Spengler reaction
Arguably the most important way of synthesizing THβCs has historically been via the
PSR. Tremendous progress has been made over the years since Pictet and Spengler’s
original synthesis of THIQs. The most important developments being the extension from
the use of phenethylamines to include tryptamines and the introduction of non-aqueous
conditions, subsequently leading to the diastereoselective PSR by using chiral tryptophan
derivatives as the amine condensation partner.60, 63  The mechanism of the
diastereoselective PSR is a complicated, but interesting one. Essentially most changes to
the reaction conditions have an impact on the selectivity outcome, e.g. acidic versus
aprotic conditions, the size and electronic effect of the Na (if any) substituent, the size and
electronic effect of the tryptophan ester group and the size and electronic effect on the
electrophile. However, as a broad generalization, as the studies of Cook has shown, trans
selectivity, i.e. trans between the tryptophan ester group and the emerging C-1 substituent,
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Scheme 13. Diastereoselective PSR mechanism
is far easier to achieve than cis.64 But, as one might also expect, there are examples in the
literature of highly cis selective PSRs, developed most extensively by Bailey.65 However,
things are further complicated by the fact that THβC tend to epimerize at the C-1 position
under acidic conditions, towards the more thermodynamically stable product, which in
most cases tends to be the trans isomer.64 The generally accepted reaction mechanism can
be rationalized accordingly (Scheme 13). First up is the question of the Z vs E-iminium
intermediate. The E-iminium 48 is assumed to be lower in energy due to the unfavorable
interaction, present in the 49 Z-iminium, between the indole ring and the R’ group in the
transition state leading up to the spiroindolenine formation.  Cyclization of the E-iminium
is then most likely to occur from the iminium Si-face, in this case due to the
stereoelectronically favorable antiperiplanar alignment of the electron withdrawing ester
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group. Also, the intermediate spiroindoline resulting from Re-face, having all the
substituents in a syn fashion, is more sterically congested. After C-C bond migration to
furnish the carbenium intermediates 52 and 53, it is once again obvious that the
intermediate resulting from the Si-face attack is lower in energy, because of the A1,2 strain
between Nb and R’. Aromatization then leads to the corresponding cis and trans THβC.
The diastereoselective PSR has been used on multiple occasions in the synthesis of THβC
natural products. One of many example of this approach is the total synthesis of (-)-
fuchsiaefoline by Cook (Scheme 14). 66  The non-commercially available D-tryptophan 58
was prepared via first a Larock67 indolization reaction between aniline 56 and the by the
Schöllkopf68 amino acid synthesis method derived alkyne 57 followed by methylation of
the indole nitrogen, removal of the chiral auxiliary and N-benzylation. PSR between
tryptophan 58 and aldehyde 59 furnished THβCs 60 and 61, in a 2:1 (trans:cis) dr. Acidic
equilibration, of the diastereomeric mixture with TFA, furnished the trans adduct 60 as a
single isomer, which was then taken further to give (-)-fuchsiaefoline.
Scheme 14. Cook’s total synthesis of (-)-fuchsiaefoline
A long standing problem with the PSR has been the lack of enantioselective protocols.
The first enantioselective PSR was reported by Nakagawa in 1996. 69  He used
stoichiometric amounts of the chiral Lewis acid (+)-diisopinocampheylchloroborane
((+)Ipc2BCl), together with N-hydroxytryptamines and some different aliphatic and
aromatic aldehydes. The yields were in most cases good; however the enantioselectivities
were at best only moderate. The development then proceeded further leading up to the
first truly catalytic asymmetric PSR (acyl PSR) which was reported in 2004 by
Jacobsen.70 Jacobsen successfully employed a thiourea based organocatalyst 63 in the
condensation between different tryptamines 62 and various aldehydes (Scheme 15),
obtaining a small library of THβCs, generally in good yields with good enantioselectivity.
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This achievement was soon followed by other organocatalytic examples reported by
List71 and Hiemstra,72 both using chiral phosphoric Brønstedt acids.
Scheme 15. Jacobsen thiourea catalyzed acyl PSR. R = H, 5-MeO, 6-MeO; R’ =
CH(CH2CH3)2, CH(CH3)2, n-C5H11, CH2CH(CH3)2, CH2CH2OTBS
Other examples of modifications to the PSR reaction, such as the use of chiral N-
auxiliaries and the condensation of tryptamines with chiral aldehydes have also been
developed.73,74 In particular the synthesis of eudistomin C (Figure 2A), using Garner’s
aldehyde (vide supra), as the directing group is worth mentioning in this context.74a
However, conceptually these different approaches do not differ much from the examples
already presented and will therefore not be discussed in any more detail.
3.1.3. Bischler-Napieralski reaction
Another old reaction that has found extensive use in THβC (and THIQ for that matter)
synthesis is the Bischler-Napieralski reaction (BNR), discover in 1893. 75  The
methodology found great use in the early days of alkaloid chemistry, and still today
enjoys a privileged position as an attractive way of making complex natural products. The
reaction in its simplest form is the ring closure of the generalized  tryptophan amide 65  to
Scheme 16. Generic BNR of amide 65
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give a 3,4-dihydro-β-carboline (DHβC) 66, by use of a dehydrating reagent such as POCl3,
PCl5, ZnCl2, SOCl2 or AlCl3. The resulting DHβC can then be reduced under various
conditions to give the corresponding THβC 67.76
In the now classic total synthesis of reserpine, Woodward utilized the Bischler-
Napieralski reaction on an advanced intermediate 68 which was dehydrated using POCl3
to give DHβC 69 (Scheme 17). NaBH4 reduction, with the hydride addition occurring
from the opposite face of the trans decalin ring structure gave the expected THβC 70,
with the wrong configuration at the THβC C-1. As it happens, 70 is not only the kinetic
product originating from the NaBH4 reduction but it is also the more thermodynamically
stable THβC diastereomer, so simple acidic equilibration, via epimerization of the THβC
(vide supra), does not lead to the correct product. This is due to the substituents all being
equatorial on ring E in the most energetically favorable conformation of 70. Inverting the
C-1 stereochemistry would inadvertently place the E-ring substituents in an axial position,
causing a more strained system. However by tethering the E ring as lactone 71,
Woodward could shift the equilibrium. By treating lactone 71 with acid some of the
forced strain within the molecule was relieved by flipping the indole ring segment away
from the D/E-ring system leading to a more stable lactone 72, having the correct C-1
stereochemistry. Simple lactone ring opening, using NaOMe, and introduction of the
3,4,5-trimethoxy benzoic acid  then gave reserpine.77  Woodward’s  synthesis of reserpine
Scheme 17. Woodward’s total synthesis of reserpine
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wherein internal asymmetric induction dictates the C-1 stereochemical outcome will
serve to illustrate an example of diastereocontrol in the BNR/reduction synthesis of
THβC.
With the introduction of catalytic asymmetric reduction reaction relying on external
induction, in the form of chiral ligands, chemists soon found a way to combine the old
(BNR) with the new (catalytic asymmetric hydrogenation). The first one to extend the
new technology towards the THβC was Noyori (Scheme 18). 78  The DHβCs 74,
synthesized by the BNR from amides 73, was subjected to asymmetric reduction under
catalytic transfer hydrogenation (CTH) conditions, catalyzed by chiral Ru(II) catalyst 75,
to give THβC 76 in good yields and excellent enantioselectivity. Only two examples of
THβCs were included in this first preliminary study and when scaling up the procedure to
a 20 mmol scale, 76a was obtained in good yield but with a slightly diminished ee of 93%,
in comparison to the 97% ee obtained on a 1 mmol scale. The drop in ee could most
likely be attributed to the lowering of the catalyst loading, extending the reaction time to
12 hours, inducing acid-catalyzed racemization of the THβC 76a vide supra under the
slightly acidic reaction conditions.
Scheme 18. Noyori’s asymmetric CTH of DHβCs. Ts = tosyl
As a final example of the BNR approach, an example of the Noyori protocol in the
synthesis of natural products is given, i.e. the synthesis of (-)-arborescidine C (Scheme
19).79 Once again, DHβC 78 was prepared by the BNR. Treatment of DHβC 78 under
Noyori’s asymmetric CTH conditions furnished THβC 79 in good yield and in good
enantioselectivity. The THβC 79 could then be taken through a 5-step reaction sequence,
to give (-)-arborescidine C in a straightforward approach. Also, (+)-arborescidine A and
(-)-arborescidine B was prepared in an analogous fashion during the same study.
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Scheme 19. Total synthesis of (-)-arborescidine C by use of Noyori’s asymmetric CTH
protocol
3.1.4. Meyers’ formamidine carbanion chemistry
An attractive reaction in organic synthesis is the direct functionalization of the α-position
to an amine.80 One such methodology was developed by Meyers, who activated the α-
position, by introducing a formamidine group on the amine, making it more susceptible to
metalation by strong lithium bases.81 By quenching the lithiated formamidine with a
suitable electrophile, a facile C-C bond forming reaction was achieved. The reaction
scope was explored and soon extended to include C-1 functionalization of tryptolines (for
the structure of tryptoline see Figure 2A).82 Formamidine 80, synthesized from tryptoline
in two steps, underwent metalation upon treatment with t-BuLi. Quenching the reaction
with various electrophiles gave C-1 substituted THβCs 81 in good yields (Scheme 20).
Scheme 20. Concept of Meyers’ formamidine chemistry in the synthesis of THβCs. E =
electrophile
It did not take long until Meyers extended the reaction scope even further enabling the
reaction to be performed in an asymmetric fashion. The asymmetric formamidine
protocol, using chiral auxiliaries, was also extended towards the THβCs. The first
example was in the total synthesis of (-)-deplancheine (Scheme 21).83 By lithiating the
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chiral formamidine 82, derived from tryptoline and L-valine, with n-BuLi and quenching
the reaction with electrophile 83, THβC 84 was obtained in 91% yield and an impressive
96.5% ee. Formamidine cleavage mediated by hydrazine in MeOH and AcOH followed
by TBS group cleavage and methoxymethyl group removal gave THβC 85 in 64% yield.
The synthesis was completed by subjecting 85 to an Appel reaction giving (-)-
deplancheine in 80% yield.
Scheme 21. Meyers’ total synthesis of (-)-deplancheine
3.1.5. Nucleophilic addition to DHβCs and βCs
The last examples of asymmetric THβC synthesis will be on the addition of carbon
nucleophiles to DHβCs. Early, achiral, examples of this particular approach include a
Barbier type reaction of alkyl halides with DHβCs mediated by zinc,84 an aza-Diels-Alder
reaction of DHβCs in the presence of methyl pentadienoate, 85  addition of Grignard
reagent to a BF3 preactivated DHβC86 and addition of 1-(trimethylsiloxy)-1,3-butadiene to
an acyl iminium salt of a DHβC.87 More recently, asymmetric versions have emerged.
One of the first was the addition of allylzinc derivatives, in combination with a lithiated
bis-oxazoline (BOX) ligand, to give two different DHβCs in good yields and good
enantioselectivity.88 Another example is the proline catalyzed asymmetric addition of
ketones and α,β-unsaturated ketones to DHβC by Itoh (Scheme 22).89 Itoh and coworkers
managed to obtain good yield and high enantioselectivities under the organocatalytic
reaction conditions, albeit at long reaction times. He also managed to extend the protocol
to the total synthesis of ent-dihydrocorynantheol. First tertacyclic ketone 89 was first
obtained in a one-step reaction between DHβC 86 and α,β-unsaturated ketone 88,
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catalyzed by L-proline, Itoh synthesized tetracyclic ketone 89 in a remarkable
enantioselectivity and diastereoselectivity. Elegant as the reaction was they were however
unable to determine if the reaction proceeded via a Mannich-Michael or a hetero-Diels-
Alder pathway. ent-Dihydrocorynantheol was obtained after three further reaction steps.
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Scheme 22. Itoh's proline catalyzed synthesis of THβC. Total synthesis of ent-
dihydrocorynantheol
One of the most recent examples of the asymmetric nucleophilic addition to DHβC was
reported by Jacobsen in 2013, which in principle is an extension of the work of Itoh.
Jacobsen and coworkers employed an organocatalytic formal aza-Diels-Alder reaction
catalyzed by a chiral primary aminothiourea organocatalyst 92 to gain access to a range
of tetracyclic THβCs 93 (Scheme 23).90 Generally excellent yields were obtained, and the
reaction was shown to tolerate a range of substituents, mainly on R5, with reaction times
ranging between 30 h – 8 days. Excellent ee’s were obtained and in most cases also high
dr’s.
As a last example a close cousin to the above mentioned reaction, i.e. the analogous
addition of nucleophiles to βCs, will be briefly mentioned. The procedure was
demonstrated in an asymmetric fashion by Ohsawa who installed an L-proline derived
chiral auxiliary on the indole N-1 position and subsequently treated the βC with allyl
stannane together with a chloroformate activating group to give the corresponding 1,2-
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DHβC in good enantioselectivity (see chapter 3.2). Reduction of the 3,4-double bond then
gave a allylated THβC.91
Scheme 23. Jacobsen’s organocatalytic formal aza-Diels-Alder reaction. R1 = H, Cl; R2 =
H, OMe; R3 = H, Et; R4 = H, Me; R5 = H, Met, n-Pr, i-Pr, t-Bu, Ph, 2-pyrryl, 4-pyridinyl,
2-furyl, 3-furyl, 2-thiophenyl, various Ar (electron donating and withdrawing)
3.2. Synthesis of harmicine
The story of harmicine is from many perspectives an interesting one, some of which will
be disclosed in the following chapter. For a more thorough account on the history of
harmicine and its applications, the reader is referred to manuscript I. Harmicine was first
isolated from natural sources, Kopsia griffithii, in 1998. The novel tetracyclic structure
was elucidated, and the basic ethanolic fraction from which the harmicine was isolated
was also shown to possess anti-leishmania activity.92 An interesting side note to this
isolation is the peculiar statement regarding the absolute configuration of harmicine. The
authors stated in the article that the presence of Wenkert-Bohlmann absorbtion bands in
the IR spectrum of harmicine would indicate that H-11b must be in an α-alignment,
which based on their chosen way of drawing the molecules must translate to an (S)-
configuration according to the Cahn-Ingold-Prelog (CIP) priority rule system (Scheme
24). 93  Assigning absolute  stereochemistry  by  the  presence  of  the Wenkert-Bohlmann
Scheme 24. Harmicine and the originally proposed absolute configuration
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absorption bands, which of course are present in both the (S) and the (R)-stereoisomers, is
erroneous – as is the use of the α/β-nomenclature in this case. Yet another interesting side
note is that harmicine was first synthesized in racemic form already 42 years prior its
isolation.94
In any case, the stereochemical assignment was taken literally in the first asymmetric
total synthesis of harmicine, leading to the wrong enantiomer being synthesized.95 In this
first synthesis, Ohsawa treated βC 94, carrying a chiral auxiliary at the indole N-1
position, with allylstannane in the presence of Troc-Cl,91 giving a 1,2-DHβC, which was
then subjected to removal of the chiral auxiliary and reduction of the 1,2-double bond to
give THβC 95. Hydroboration followed by hydrogen peroxide oxidation gave alcohol 96.
Troc group removal, followed by cyclization under Mitsunobu conditions gave (S)-
harmicine. Optical rotation measurement of the final product indicated that they had
synthesized the enantiomer of natural harmicine.
Scheme 25. Ohsawa's total synthesis of harmicine. Troc = 2,2,2-trichloroethoxycarbonyl;
All = allyl; Pg* = (S)-N-(9-anthracenylmethyl)pyroglutaminyl
The first asymmetric synthesis of the naturally occurring enantiomer of harmicine can be
attributed to Czarnocki.96 Here the BNR was utilized in combination with the asymmetric
Noyori transfer hydrogenation (Scheme 18) of the resulting iminium.78 The short and
straightforward synthesis started with preparation of the tetracyclic iminium salt 98, by
condensation between tryptamine and γ-butyrolactone followed by a BNR. The iminium
salt was then reduced by the slightly modified Noyori type asymmetric CTH catalyst 99
in an azeotropic mixture of formic acid and Et3N to give (R)-harmicine in 63% yield over
3 steps, albeit in a moderate ee of 79%.
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Scheme 26. Czarnocki’s total synthesis of the natural enantiomer of harmicine
Our interest in harmicine arose during our attempts to develop a novel route towards the
THβC scaffold based on a chiral pool approach starting from amino acids. Aware of the
inherent configurational instability of amino acid derived carbonyl compounds we opted
to employ a Pf-protecting group strategy to maintain the stereochemical integrity of the
chiral center (Figure 2B). This led us to explore the synthesis of harmicine starting from
proline (Scheme 27).II Our synthesis started with proline which was Pf-protected under
slightly modified literature conditions.20 We found it necessary to replace Et3N (pKaH
10.75) with NMM (pKaH 7.38) due to the observation of small amounts of racemization in
the Pf-protection step, most likely taking place on the TMS-ester intermediate. Weinreb
amide 100 was then obtained via a T3P® coupling of HCl·HN(OMe)Me, assisted by
catalytic amounts of DMAP.52 Lithiated Boc-o-toluidine 101 97 , 98  was added to the
Weinreb amide to give ketone 102 in good yield. Regioselective enolization, directed by
the Pf-group, and quenching of the reaction with ethyl iodoacetate gave a 1:1
diastereomeric mixture of the 1,4-dicarbonyl 103.  Direct treatment of the mixture after
an aqueous work up with acid facilitated Boc-group removal with sequential indolization
to give indole 104. The next step, Pf-group removal, proved more cumbersome than first
anticipated. Hydrogenolysis under standard conditions, using Pd/C and H2(g), failed to
give any conversion. Turning to CTH conditions and performing a scan of hydrogen
sources revealed Pd/C in combination with NH4H2PO2 as a suitable system. Pf-group
cleavage under these CTH conditions followed by C-ring closure and reduction of the
intermediate lactam with LAH furnished harmicine. The reaction sequence was optimized,
eliminating all silica gel chromatography purification, and scaled up to give >1 gram of
enantiopure harmicine. Both (S)  and  (R)-harmicine was synthesized from L- and D-
proline, respectively.
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Scheme 27. Synthesis of harmicine developed in the course of this work
Recently harmicine was attributed to possess potent antinociceptive properties. 99 The
mechanism of its action was however not made completely clear, however preliminary
evidence pointed away from the opioid receptor regulating pain system. The same study
also indicated that harmicine did not seem to act via an anti-inflammatory pathway. The
study did not include any information regarding harmicine’s activity towards the
cannabinoid receptor system (CB1 and  CB2), which prompted us to evaluate if such
interaction might be responsible for the perceived antinociceptive effect.100 The results
are summarized in Table 2. Non-natural (S)-harmicine showed very weak agonist affinity
towards both CB1 and CB2, while (R)-harmicine showed no activity. It is interesting to
note that there is some selectivity preference on the absolute configuration of harmicine
towards the cannabinoid receptors. However, these results are more a curiosity since the
low affinity could not serve to explain harmicine’s antinociceptive properties via the
endocannabinoid system.101
Important features of the synthesis presented above includes the modified Pf-protection,
the T3P mediated amide coupling and the CTH hydrogenolysis cleavage of the Pf-group
(to our knowledge it is the first reported Pf-group removal under CTH conditions).
Moreover, the chromatography free nature of the synthesis leading to gram amounts of
harmicine and the complete retention in configuration at the α-amino carbonyl
41
stereocenter, especially during the lateral lithiation and during the enolazation reactions
makes the synthesis an attractive alternative to existing protocols.
Table 2. Affinity of harmicine towards cannabinoid receptors (CB1 and CB2)
Compound
CB1 agonist
activity[a]
CB1 antagonist
activity[a]
CB2 agonist
activity[b]
[35S]GTPγS
binding [%][c]
[35S]GTPγS binding
[% HU-210-evoked
response][c]
[35S]GTPγS
binding [%][c]
(10μM)
101 100 108
(10 μM)
133 105 121
HU-210[d] 449(10 nM) -
174
(1 μM)
AM-251[e]
(1 μM) 84 37 -
SR-144,528[f]
(1 μM) - - 54
[a] rat cerebellar membranes; [b] hCB2-CHO cell membrane; [c] mean value [d] cannabinoid receptor
(CB1 and CB2) full agonist; [e] cannabinoid receptor (CB1) antagonist/inverse agonist; [f] cannabinoid
receptor (CB2) antagonist/inverse agonist
3.3. Synthesis of eleagnine
The harmicine study was further extended to the synthesis of (S)-eleagnine.III Eleagnine, a
member of the simple THβCs, was originally isolated in its racemic form in 1950 from
Elaeagnus angustifolia, and has since then also been found from various other plant
sources.57,102 Recently, the alkaloids have also been identified in common food stuff, such
as chocolate and soy sauce.103 The route, a modified version of the harmicine synthesis,
started with the Pf-protection of commercially available methyl ester 105. By use of the
methyl ester, no in situ TMS protection of the carboxylic acid was necessary, simplifying
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the reaction procedure in a practical aspect. The corresponding proline methyl ester could
also be Pf-protected using the same procedure, however a slight drop in ee was
observed.II Morpholine amide 106 was prepared, which represents a cheaper albeit less
reactive option to the more commonly used Weinreb amides (Scheme 28).104 The amide
switch was made due to the observation of decomposition of Weinreb amide 111 upon
treatment with dilithiated N-Boc-o-toluidine 101, leading to low yields of the desired
product 107 and the isolation of byproducts 112 and 113 (Scheme 29). We attributed the
reaction outcome of Weinreb amide 111 to the free N-H proton leading to quenching of
the nucleophile 101, subsequently resulting in decomposition via an intramolecular
pathway by proton abstraction from either the N-Me or the N-OMe group. Analogous
decomposition of Weinreb amides have been observed on a number of occasions.105
Morpholine amide 106, lacking the possibility to decompose in the same fashion as the
Weinreb amides, was therefore introduced. Treatment of compound amide 106 with
dilithiated Boc-o-toluidine 101 satisfyingly gave ketone 107 in good yield. The next
surprise came during the addition of ethyl bromoacetate to the potassium enolate of
ketone 107, when the tricyclic γ-lactones 108 and 109 were obtained. The diastereomeric
ratio of 108 and 109 at 0 oC was determined to be 1:1 by NMR. The ratio could be
improved to 6:1 (108:109) by lowering the reaction temperature to -78 oC, although at a
cost in the isolated yield of 108, 45%. The diastereomeric ratio of 108 and 109 was
however of no consequence, so the 1:1 mixture of lactones 108 and 109  was treated  with
Scheme 28. Synthesis of (S)-eleagnine developed in the course of this work
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methanolic sulfuric acid, to facilitate sequential Boc-group cleavage, indolization and
methyl esterification giving indole 110. Pf-group removal followed by C-ring formation
and reduction of the intermediate amide gave (S)-eleagnine in >99% ee, as confirmed by
enantioselective HPLC analysis. The sequence could easily be scaled up to gram
quantities, giving 1.4 g of enantiopure (S)-eleagnine in one batch. The synthesis illustrates
that the presented strategy towards THβC can be applied on a broader range of amino
acid substrates, as will be further presented in the following chapter.IV
Scheme 29. Decomposition of Weinreb amide 111. Reaction conditions: 111 (100 mol-%)
was treated with 101 (110 mol-%) at -30 oC. The reaction was stirred for 1 h. Isolated
yields after silica gel chromatography.
3.4. Synthesis of 2-indolyl methanamines
A group of compounds structurally related to the THβCs is the 2-indolyl methanamines,
which contain all the same structural features with the exception of the ethenyl-bridge
connecting the C-ring nitrogen and the indole C-3 position. Despite the close resemblance,
reports of such compounds in the literature are scarce. Only one natural product carrying
the 2-indolyl methanamine framework with an unsubstituted indole C-3 position,
vinoxine,106 has been isolated to date. However, some other closely related compounds of
interest do exist as exemplified by calindol, a synthetic 2-indolyl methanamine with high
affinity towards the calcium sensing receptor, 107  and the natural products
cinchonamine,108 guettardine109 and protoaculeine B110 (Scheme 30). A unifying factor for
the aforementioned compounds is that they are not accessible via conventional THβC
methods (vide supra). We therefore found it appropriate to expand the scope of the THβC
synthesis methodology described in the previous chapters, to also include 2-indolyl
methanamines.IV A few examples of the synthesis of chiral 2-indolyl methanamines do
exist in the literature, including the following: resolution of hydroxyureas, 111
diastereoselective addition of 2-lithiated indoles to either hydrazones 112  or imines 113
carrying a chiral directing group, Pd catalyzed Sonogashira/cyclization of chiral
propargylamines and 2-iodo anilines,114 enantioselective chiral phosphoric acid catalyzed
Friedel-Crafts/oxidation protocol115 and finally a three component domino reaction of 2-
ethynylanilines, aldehydes and secondary amines – catalyzed by Cu(I)116.
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Scheme 30. Examples of 2-indolyl methanamines
Four amino acids were selected as suitable starting material in the 2-indolyl methanamine
synthesis, and chosen on the basis of gaining a large structural diversity. Ketones 102II
and 107III was prepared as previously described and ketones 115 and 117 were prepared
in an analogous fashion (Scheme 31). The corresponding morpholine amide of the
phenylalanine derived Weinreb amide 114 proved too unreactive in the lateral lithiation,
most likely due to the added steric bulk of the phenyl group. However, the decomposition
pattern observed for Weinreb amide 111 (Scheme 29), was not observed for Weinreb
amide 114, despite the presence of a free N-H proton. Performing a reaction temperature
optimization for the lateral lithiation of Weinreb amide 114 we found that a good yield of
77% could be obtained at -40 °C.
With the ketones 102, 107, 115 and 117 in hand, the Boc-group cleavage/indolization was
studied. Ketones 102, 107 and 115 underwent smooth reaction in ethanolic sulfuric acid,
using CH2Cl2 as a co-solvent, giving indoles 118a-c. However, the reaction of ketone 117
proved to be slightly more complicated. Treatment of ketone 117 under the same reaction
conditions only partially cleaved the Boc-group, which led to low yields of indole 119.
Also a rearrangement of the methylene group to indole aminal 120 was observed under
the acidic reaction conditions. In order to bypass these problems, treatment of ketone 117
under less acidic conditions, leaving the Boc group intact and preventing the formation of
aminal 120, followed by aminal cleavage using hydroxyl amine and telescoping the
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reaction further by performing the indole-Boc cleavage under basic conditions furnished
the desired indole 118d.
Scheme 31. Synthesis of ketones 115 and 117
Scheme 32. Indolization of ketones 102, 107, 115 and 117
The Pf-protected 2-indolyl methanamines were then deprotected by Pd/C catalyzed
hydrogenolysis, acylated (by either Ac2O or AcCl) and methylated by reductive
amination (using formaldehyde and NaBH(OAc)3) 117  to provide a small library of
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compounds (Scheme 33). The enantiopurity was once again determined to be at least 99%
ee for all reported 2-indolyl methanamines.
Scheme 33. 2-indolyl methanamines synthesized.
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4. Conformational study of Pf-protected α-amino carbonyl
compounds
As stated in Chapter 2.1, the mechanism by which the Pf-group manages to maintain the
stereochemical integrity of α-amino derivatives under strongly basic reaction conditions
has not been fully elucidated. Prior to this work no thorough studies had yet to be
undertaken, which prompted us to investigate the phenomenon, by X-ray crystallographic
measurements, DFT calculations and NMR data.
4.1. Computational study
We started by trying to reproduce the MM calculations which had placed the H(4) (for
atom numbering see Figure 4) antiperiplanar (or alternatively periplanar) to the C(2)-O(1)
double bond.24 A simple substrate, methyl ester 124, was chosen as a model compound
upon which the calculations were subsequently performed. By performing a
conformational search, applying the MM2*118 and MM3*119 force fields we were able to
satisfactorily reproduce the aforementioned results (Table 3). However, when doing a
small force field scan, employing also MMFF120 (and MMFFs) and OPLS-2005,121 a clear
variation in the data output could be observed. This variation puts the previously
postulated stereoelectronic effects under question. We proceeded by refining the OPLS-
2005 conformational search by quantum mechanical (QM) density functional theory
(DFT) calculations at the M06-2X/6-31G**++ level of theory.122 The global minimum
was found to attain a H(4)-C(3)-C(2)-O(1) dihedral angle of -162 ° (entry 5, conformer 1,
Table 3).
Figure 4. Generic Pf-protected α-amino carbonyl compound and 124. Numbering (does
not follow IUPAC guidelines) of relevant atoms to simplify the conformational
(computational and crystallographic) discussion.
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Table 3. Molecular mechanics conformational search on 124, showing data for the 5
lowest energy conformationsa
Entry Force Field Conformer Dihedral
angle[b]
[o]
Energy[c]
[kJ/mol]
Population
distribution[d]
[%]
1 MM2* 1 -177 0 84.5
2 2 5.0 11.3
3 -150 8.9 2.3
4 32 12.3 0.6
5 119 13.8 0.3
2 MM3* 1 179 0 87.4
2 13 7.1 5.0
3 38 8.1 3.4
4 170 10.2 1.4
5 26 10.2 1.4
3 MMFF[e] 1 -155 0 92.7
2 -148 8.6 2.8
3 34 9.3 2.2
4 27 9.8 1.8
5 -167 13.1 0.5
4 OPLS-2005 1 10 0 35.4
2 -139 0.4 29.8
3 -155 2.6 12.4
4 -143 3.1 10.1
5 16 6.3 2.8
5 OPLS-2005 1 -162 0 69.6
(QM-refined)[f] 2 -151 4.5 11.2
3 19 4.7 10.5
4 35 5.6 7.4
5 16 12.0 0.5
[a] MM calculations performed in gas phase using MacroModel 10.0, without any constraints; electrostatic
treatment was set to constant dielectric; [b] Dihedral angle between H(4)-C(3)-C(2)-O(1); [c] Relative
potential energy; [d] Determined as the Boltzmann distribution at T = 298.15 K; [e] MMFFs gave identical
results; [f] Calculations performed in gas phase using Jaguar 8.0; theory: DFT (M06-2X) with the basis set 6-
31G**++.
The calculated lowest energy conformation of 124 was also largely supported by
crystallographic data of the same compound (Figure 5).
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Figure 5. A: Lowest calculated energy conformation of 124; B: crystal structure of 124
Figure 6. Coordinate scan of 105 and 124, rotation around the C(2)-C(3) bond in 10o
increments. Calculations performed in gas phase using Jaguar 8.0; theory: DFT(B3LYP)
with the basis set 6-31G**. Energy: relative total electronic energy.
At this stage we found it relevant to examine the rotational barrier around the C(2)-C(3)
bond. The lowest energy conformation of 124 was thus subjected to a coordinate scan
wherein the abovementioned bond was rotated in 10 ° increments. The calculations were
performed at the B3LYP/6-31G** level of theory (Figure 6). 123  Next, the same
calculation sequence was also performed on alanine methyl ester 105. Not surprisingly,
the bulky Pf-group on 124 added a significant amount of torsional strain to the system
when comparing to the free base of methyl ester 105; however, the energy barriers are not
as high as anticipated. The observed energy barrier is mostly an effect of the amino acid
side chain being forced into close proximity of the Pf-group. Only 7 kJ/mol (1.7 kcal/mol)
of energy is required to forcibly align the H(4) σ-sigma orbital with the π*-orbital of the
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carbonyl double bond, making a deprotonation reaction a feasible event. However, worth
mentioning is that H(4) is kept, all through the coordination scan, dead center over the
fluorenyl ring system, possibly imposing large enough steric shielding to prevent
deprotonation from occurring.
4.2. NMR
The close proximity of the H(4) to the Pf-ring system was also observed in solution by
the use of NMR spectroscopy. The chemical shift of H(4) (δ 2.78)124 can be compared
with the corresponding proton in N-Bn-alanine methyl ester 125 (δ 3.37), indication a
strong shielding effect on H(4) invoked by anisotropic effect of the Pf-ring system. A
NOESY coupling between H(4) and the Pf-group in 124 was also observed.
Figure 7. Chemical shifts of the α-hydrogens in amino esters 124 and 125
4.3. Crystallographic data
During the course of the above mentioned investigations (chapter 3.2, 3.3 and 3.4) a
number of crystalline N-Pf α-amino carbonyl compounds were isolated, mounting out to
eight X-ray crystal structures being obtained (Figure 8, Table 4).
Figure 8. α-amino carbonyl compounds of which X-ray crystal structures were obtained
Some interesting trends can be observed from the crystal structure data. In all but one
case, proline methyl ester 127, H(4) is aligned on top of the fluorenyl ring system as
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observed in the computational study. In 127, however, H(4) is situated in the space
between the Pf phenyl group and the fluorenyl group. It is also evident that the H(4)-
C(3)-C(2)-O(1) dihedral angle in broad terms matches the calculated angle for methyl
ester 124. Furthermore, the H(4)-C(3) bond is syn-periplanar to the N(6)-C(7) bond,
indicating a favorable conformation for a concerted E2 syn-elimination reaction. This
orbital alignment might help explain the observed Pf-anion elimination from N-Pf-
alaninal 5 under basic conditions (Scheme 3).7
Table 4. Dihedral angles from X-ray crystal structure data
Compound Dihedral angle [o]
H(4)-C(3)-C(2)-O(1)
Dihedral angle [o]
H(4)-C(3)-N(6)-C(7)
Dihedral angle [o]
C(3)-N(6)-C(7)-C(8)
124 -120 5 -175
111 -147 23 172
128 [a] 19/23 (44/45)[b] -12.5/-24 (19/15) 178/178 (179/177)
129 -149 26 177
126 -153 31 176
114 [c] -153/-150 29/32 -177/179
127 -149 3 61
100 -161 28 174
[a] Structure data contains four crystallographically independent molecules, two in the NH/COOH state
and two in the NH2+/COO- state (zwitterionic forms shown in brackets); [b] Angle between only one of
the carboxylates oxygens presented; [c] Structure data contains two crystallographically independent
molecules.
4.4. Conclusions
The calculated rotational barrier about the C(3)-C(2) bond in N-Pf alanine methyl ester
124 is too low to simplify the mechanism behind the stereochemical protecting effect
through such an argument. However, it is obvious that H(4) is kept in close proximity to
the Pf fluorenyl ring system, causing at the very least a significant amounts of steric
shielding, which most likely leads to a certain hampering of a
deprotonation/reprotonation pathway. Furthermore, as already speculated by Rapoport, it
might be a cause to assume that a Pf-elimination pathway is favored over the enolization
pathway due to the periplanar alignment of the H(4)-C(3) and the N(6)-C(7) bonds.7 To
summarize, after computational conformation analysis coupled with NMR data and X-ray
crystal data we have not found any hard evidence supporting the previously proposed
stereoelectronic argument regarding the stability of N-Pf protected α-amino carbonyl
derivatives. It is important to note that the discussion herein does not take into account
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the possible increased energy barrier the Pf-group might induce in the enolization
transition state, when the sp3 carbon rehybridizes to sp2, originating from the extra allylic
strain the Pf-group might impose upon the system.  To further probe such effects more
rigorous calculations would be necessary.
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5. General conclusions
The work presented in this thesis describes a novel synthetic strategy towards C-1
substituted chiral THβCs by use of a chiral pool strategy, starting from amino acids. The
amino acid side chain was shown to be efficiently transferred through the reaction
sequence to the final products with full retention of stereochemical information. A Pf-
protecting group strategy was employed to protect the vulnerable stereocenter on the α-
amino carbonyl derivatives from racemization. The strategy culminated in the synthesis
of two bioactive THβC natural products in gram quantities, without any erosion of the
optical purity (ee ≥ 99%) of the amino acid starting material, via the novel route.
The strategy was also extended to include a class of compounds underrepresented in the
literature – the 2-indolyl methanamines. The compound class, unobtainable by
conventional THβC synthetic methodologies, i.e. PSR and BNR, was readily synthesized
by the Pf-protecting group/chiral pool strategy. A small library of 2-indolyl
methanamines, starting from 4 structurally different amino acids, was synthesized.
The results presented herein shows that the THβC compound class is readily obtained
from the described amino acid chiral pool strategy, and that the methodology offers a
good alternative to traditional THβC synthesis.
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